AP — Oscar-winning actress Angelina Jolie announced in an oped in the New York Times on Tuesday that she had a preventative mastectomy after learning she had a gene that significantly raised her risk of breast cancer. Here’s a crash course in the procedure Jolie had and why.
What kind of surgery did Jolie have?
Jolie had a preventative double mastectomy, meaning she chose to have both her breasts removed even though she had not been diagnosed with cancer.
Why did she have the mastectomies?
Jolie says that she has a “faulty” version of the BRCA1 gene that means she has an 87 percent chance of getting breast cancer. By having both breasts removed preventatively, she said her breast cancer risk drops to 5 percent.
What did the procedure involve?
In double mastectomies, surgeons typically remove as much breast tissue as possible. In Jolie’s case, because she was having a reconstruction done shortly afterward, the doctors preserved the skin covering her breasts, inserting “fillers” where the breast tissue would have been, to keep the skin elastic. According to Jolie, she had implants put in nine weeks later.
How many women have this faulty gene?
Only a small percentage of women have this same faulty gene, or a similar mutated version of a related gene, BRCA 2. These mutations are most commonly found in women of Eastern European Jewish descent; one study found 2.3 percent of women in that group had the mutations — about five times higher than in the general population. Other ethnic groups, including the Norwegian, Dutch and Icelandic people, also have slightly higher rates of these mutations.
How do these genes increase a woman’s risk of breast cancer?
The average woman has a 12 percent risk of developing breast cancer sometime during her life. In comparison, women who have inherited a faulty version of a breast cancer gene are about five times more likely to get breast cancer. In the US, about 5 to 10 percent of breast cancers are thought to be linked to harmful versions of the BRCA1 and BRCA2 genes.
How can women find out if they have these gene mutations?
A genetic test using a blood test can usually detect these genes. In the US, there are no standard guidelines recommending women for BRCA1 or BRCA2 genetic testing. The tests usually cost at least several hundred dollars.
What other options might Jolie have had?
Doctors would likely have suggested earlier screening tests, including mammograms or MRIs, although those would only help them spot breast cancer earlier, not prevent it. They might also consider using breast cancer drugs preventively, though trials into their long-term use is still ongoing. “This is not a decision that people take lightly,” said Dr. Emma Pennery, clinical director at the British charity, Breast Cancer Care. “You cannot decide to have a double mastectomy next week.”
Copyright 2013 The Associated Press
The Times of Israel covers one of the most complicated, and contentious, parts of the world. Determined to keep readers fully informed and enable them to form and flesh out their own opinions, The Times of Israel has gradually established itself as the leading source of independent and fair-minded journalism on Israel, the region and the Jewish world.
We've achieved this by investing ever-greater resources in our journalism while keeping all of the content on our site free.
Unlike many other news sites, we have not put up a paywall. But we would like to invite readers who can afford to do so, and for whom The Times of Israel has become important, to help support our journalism by joining The Times of Israel Community. Join now and for as little as $6 a month you can both help ensure our ongoing investment in quality journalism, and enjoy special status and benefits as a Times of Israel Community member.